Enhance your practice with CME and tools that focus on the management of neurological conditions.
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Navigating Emerging Biomarkers in MS Care
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
Immunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
David Weisman, MD
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
The New Era of Targeted Therapy for Myasthenia Gravis
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
Outcome Measures Capture Progression in Late-Onset TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.